Replies to post #9120 on CytoSorbents Corporation (CTSO)

[cars100cars]

HadTo, your "sales" numbers are directionally correct, but they also include grant money. "Product sales" for CytoSorb are slightly lower. Your numbers are "total revenues." Just the same, I agree with your premise that the market should recognize the growth in sales...and the more than doubling of gross profit YoY in 2016 to about $5.5M. Should this trend persist which I believe it will, then investors should see the end to the downward trend in earnings (-$11M in 2016). This is the key factor to the market. CTSO must tell a compelling financial story with facts and figures in this next analysts' meeting. Investors want to see further acceleration in sales/revenues and an improvement in earnings. Then the stock price will go higher.